Core & Main (CNM) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
31 Jan, 2026Executive summary
Net sales reached $1.74 billion for Q1 2024, up 11% year-over-year, driven by acquisitions and healthy end market demand.
Adjusted EBITDA declined 1% to $217 million, with margin compressing 150 basis points to 12.5% due to gross margin normalization and higher inventory costs.
Net income for the quarter was $101 million, down 24.1% year-over-year, primarily due to higher SG&A, amortization, and interest expenses.
Five acquisitions closed during and after the quarter, including Dana Kepner, expanding geographic reach and product offerings.
Operating cash flow was $78 million, reflecting positive cash generation in a seasonally lower quarter.
Financial highlights
Gross profit increased 6.6% to $468 million, but gross margin declined to 26.9% from 27.9% year-over-year due to higher inventory costs and competitive pressures.
Net debt leverage increased to 2.7x from 1.7x a year ago, reflecting higher borrowings for acquisitions.
Total debt at quarter-end was $2,449 million, with $241 million outstanding on the $1,250 million ABL facility and $993 million available.
SG&A expenses rose 15.2% to $257 million, representing 14.8% of net sales.
Diluted EPS decreased 2% to $0.49.
Outlook and guidance
Fiscal 2024 net sales guidance raised to $7.5–$7.6 billion, representing 12–13% year-over-year growth.
Adjusted EBITDA guidance increased to $935–$975 million, up 3–7% year-over-year.
M&A expected to contribute 7–8% of total sales growth in 2024; organic sales growth projected in low single digits.
Adjusted EBITDA margin projected at 12.5–12.8% for FY24.
End-market demand anticipated to remain solid through year-end, with continued market share gains.
Latest events from Core & Main
- Record Q2 sales from acquisitions offset by lower income and reduced outlook amid market headwinds.CNM
Q2 202522 Jan 2026 - Record Q3 sales, raised outlook, and strong cash flow highlight robust growth and execution.CNM
Q3 202512 Jan 2026 - Record sales and EBITDA in FY24; 2025 outlook strong with growth and stable margins.CNM
Q4 202526 Dec 2025 - Q3 net sales and profit rose, with margin expansion and increased share repurchases.CNM
Q3 202610 Dec 2025 - Record sales, new leadership, and strong governance mark this year's proxy highlights.CNM
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CNM
Proxy Filing1 Dec 2025 - Record Q1 sales up 9.8%–10%, margin gains, and FY2025 outlook reaffirmed.CNM
Q1 202610 Nov 2025 - Q2 sales rose 6.6%–7% with strong municipal demand, but 2025 guidance was lowered on higher costs.CNM
Q2 202610 Sep 2025